BRIEF published on 11/14/2025 at 18:25, 6 months 3 days ago Les actionnaires de Relief Therapeutics approuvent la fusion avec NeuroX Augmentation De Capital Approbation Des Actionnaires Thérapeutiques De Soulagement Fusion De NeuroX Changements De Leadership
BRIEF published on 11/14/2025 at 18:25, 6 months 3 days ago Relief Therapeutics Shareholders Approve Merger with NeuroX Leadership Changes Shareholder Approval Capital Increase Relief Therapeutics NeuroX Merger
PRESS RELEASE published on 11/14/2025 at 18:20, 6 months 3 days ago Relief Therapeutics Shareholders Approve Business Combination with NeuroX Relief Therapeutics shareholders approve business combination with NeuroX, creating a digital neurotherapeutics company. New board members elected. Business combination expected to close in December 2025 Shareholders Business Combination Relief Therapeutics NeuroX Digital Neurotherapeutics
BRIEF published on 10/29/2025 at 07:05, 6 months 19 days ago Relief Therapeutics annonce des résultats positifs dans l'étude RLF-OD032 Approbation De La FDA RLF-OD032 Traitement De La Phénylcétonurie Étude De Bioéquivalence Dichlorhydrate De Saproptérine
BRIEF published on 10/29/2025 at 07:05, 6 months 19 days ago Relief Therapeutics Reports Positive Outcomes in RLF-OD032 Study FDA Approval RLF-OD032 Phenylketonuria Treatment Bioequivalence Study Sapropterin Dihydrochloride
PRESS RELEASE published on 10/29/2025 at 07:00, 6 months 19 days ago Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 Relief Therapeutics announces positive results from pivotal bioequivalence study of RLF-OD032, demonstrating bioequivalence to KUVAN®, supporting NDA submission in early 2026 FDA Approval Relief Therapeutics RLF-OD032 Bioequivalence Study PKU Treatment
BRIEF published on 10/24/2025 at 07:04, 6 months 24 days ago Relief Therapeutics Schedules Extraordinary General Meeting for Business Merger Business Combination Extraordinary General Meeting Relief Therapeutics MindMaze Therapeutics NeuroX Group
BRIEF published on 10/24/2025 at 07:04, 6 months 24 days ago Relief Therapeutics convoque une assemblée générale extraordinaire pour une fusion d'entreprises Assemblée Générale Extraordinaire THÉRAPEUTIQUE DE SECOURS Regroupement D'entreprises MindMaze Therapeutics Groupe NeuroX
PRESS RELEASE published on 10/24/2025 at 06:59, 6 months 24 days ago Relief Therapeutics Convenes Extraordinary General Meeting Relief Therapeutics announces Extraordinary General Meeting to seek shareholder approval for business combination with NeuroX Group SA EGM Business Combination Extraordinary General Meeting Relief Therapeutics NeuroX Group SA
BRIEF published on 10/08/2025 at 07:05, 7 months 9 days ago Relief Therapeutics et NeuroX finalisent un accord de rapprochement commercial Fusions Et Acquisitions Technologie De La Santé Basée Sur L'IA NeuroX MindMaze Therapeutics Neurologie De Précision
Published on 05/16/2026 at 01:15, 1 day 19 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 20 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 21 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 4 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 2 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 5 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 5 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 10 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 11 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 2 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
